JW (Cayman) Therapeutics Co. Ltd (2126.HK) HKSE

3.85

+0.11(+2.94%)

Updated at October 20 09:32AM

Currency In HKD

Valuation

Market Cap497.26M
Enterprise Value162.29M
P/E Ratio-2.31
PEG Ratio0.55
Price/Sales Ratio8.01
Price/Book Ratio1.57
Enterprise/Revenue6.47
Enterprise/EBITDA-4.49

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-3.47
Operating Margin0.73

Management Effectiveness

Return On Assets-0.44
Return On Equity-0.59

Income Statement

Revenue158.22M
Revenue/Share0.43
Gross Profit77.32M
EBITDA-381.58M
Net Income-590.62M
Diluted EPS-1.43

Balance Sheet

Total Cash647.04M
Total Cash/Share1.56
Total Debt372.46M
Total Debt/Equity0.41
Current Ratio1.59
Book Value Per Share2.19

Price History

52-Week Change136.71
52-Week High6.44
52-Week Low1.23
Moving Average 50 Days4.92
Moving Average 200 Days2.84

Statistics

Average Volume4.74M
Shares Outstanding415.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A